These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 23841848)
1. Impact of siRNA overhangs for dendrimer-mediated siRNA delivery and gene silencing. Posocco P; Liu X; Laurini E; Marson D; Chen C; Liu C; Fermeglia M; Rocchi P; Pricl S; Peng L Mol Pharm; 2013 Aug; 10(8):3262-73. PubMed ID: 23841848 [TBL] [Abstract][Full Text] [Related]
2. Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer. Liu X; Liu C; Laurini E; Posocco P; Pricl S; Qu F; Rocchi P; Peng L Mol Pharm; 2012 Mar; 9(3):470-81. PubMed ID: 22208617 [TBL] [Abstract][Full Text] [Related]
3. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo. Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983 [TBL] [Abstract][Full Text] [Related]
4. Dendrimer Nanovectors for SiRNA Delivery. Liu X; Peng L Methods Mol Biol; 2016; 1364():127-42. PubMed ID: 26472447 [TBL] [Abstract][Full Text] [Related]
5. Structurally flexible triethanolamine-core poly(amidoamine) dendrimers as effective nanovectors to deliver RNAi-based therapeutics. Liu X; Liu C; Catapano CV; Peng L; Zhou J; Rocchi P Biotechnol Adv; 2014; 32(4):844-52. PubMed ID: 23938269 [TBL] [Abstract][Full Text] [Related]
6. PAMAM dendrimers for siRNA delivery: computational and experimental insights. Pavan GM; Posocco P; Tagliabue A; Maly M; Malek A; Danani A; Ragg E; Catapano CV; Pricl S Chemistry; 2010 Jul; 16(26):7781-95. PubMed ID: 20496352 [TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of Dicer-substrate siRNAs using a dual targeting peptide decorated dendrimer delivery system. Liu X; Liu C; Chen C; Bentobji M; Cheillan FA; Piana JT; Qu F; Rocchi P; Peng L Nanomedicine; 2014 Nov; 10(8):1627-36. PubMed ID: 24965758 [TBL] [Abstract][Full Text] [Related]
8. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers. Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622 [TBL] [Abstract][Full Text] [Related]
9. An amphiphilic dendrimer for effective delivery of small interfering RNA and gene silencing in vitro and in vivo. Yu T; Liu X; Bolcato-Bellemin AL; Wang Y; Liu C; Erbacher P; Qu F; Rocchi P; Behr JP; Peng L Angew Chem Int Ed Engl; 2012 Aug; 51(34):8478-84. PubMed ID: 22829421 [TBL] [Abstract][Full Text] [Related]
10. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy. Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764 [TBL] [Abstract][Full Text] [Related]
12. Acetylation of PAMAM dendrimers for cellular delivery of siRNA. Waite CL; Sparks SM; Uhrich KE; Roth CM BMC Biotechnol; 2009 Apr; 9():38. PubMed ID: 19389227 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain. Kim ID; Lim CM; Kim JB; Nam HY; Nam K; Kim SW; Park JS; Lee JK J Control Release; 2010 Mar; 142(3):422-30. PubMed ID: 19944723 [TBL] [Abstract][Full Text] [Related]
14. Mastering Dendrimer Self-Assembly for Efficient siRNA Delivery: From Conceptual Design to In Vivo Efficient Gene Silencing. Chen C; Posocco P; Liu X; Cheng Q; Laurini E; Zhou J; Liu C; Wang Y; Tang J; Col VD; Yu T; Giorgio S; Fermeglia M; Qu F; Liang Z; Rossi JJ; Liu M; Rocchi P; Pricl S; Peng L Small; 2016 Jul; 12(27):3667-76. PubMed ID: 27244195 [TBL] [Abstract][Full Text] [Related]
15. Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers. Tang Y; Li YB; Wang B; Lin RY; van Dongen M; Zurcher DM; Gu XY; Banaszak Holl MM; Liu G; Qi R Mol Pharm; 2012 Jun; 9(6):1812-21. PubMed ID: 22548294 [TBL] [Abstract][Full Text] [Related]
16. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity. Akhtar S; Benter I Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774 [TBL] [Abstract][Full Text] [Related]
17. Dendrimers as carriers for siRNA delivery and gene silencing: a review. Wu J; Huang W; He Z ScientificWorldJournal; 2013; 2013():630654. PubMed ID: 24288498 [TBL] [Abstract][Full Text] [Related]
18. Efficient siRNA delivery using a polyamidoamine dendrimer with a modified pentaerythritol core. Zhang Y; Zhou C; Kwak KJ; Wang X; Yung B; Lee LJ; Wang Y; Wang PG; Lee RJ Pharm Res; 2012 Jun; 29(6):1627-1636. PubMed ID: 22274556 [TBL] [Abstract][Full Text] [Related]
19. The design, preparation, and evaluation of asymmetric small interfering RNA for specific gene silencing in mammalian cells. Chang C; Hong SW; Dua P; Kim S; Lee DK Methods Mol Biol; 2013; 942():135-52. PubMed ID: 23027049 [TBL] [Abstract][Full Text] [Related]
20. PAMAM dendrimers mediate siRNA delivery to target Hsp27 and produce potent antiproliferative effects on prostate cancer cells. Liu XX; Rocchi P; Qu FQ; Zheng SQ; Liang ZC; Gleave M; Iovanna J; Peng L ChemMedChem; 2009 Aug; 4(8):1302-10. PubMed ID: 19533723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]